Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Standard Biotools (LAB) Accumulated Depreciation & Amortization (2016 - 2025)

Standard Biotools (LAB) has disclosed Accumulated Depreciation & Amortization for 15 consecutive years, with $47.3 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 284.24% to $47.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $47.3 million through Dec 2025, up 284.24% year-over-year, with the annual reading at $47.3 million for FY2025, 284.24% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $47.3 million at Standard Biotools, up from $46.7 million in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $70.1 million in Q1 2025, with the low at $3.2 million in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $19.7 million, with a median of $12.1 million recorded in 2022.
  • The sharpest move saw Accumulated Depreciation & Amortization tumbled 86.17% in 2023, then skyrocketed 1249.08% in 2025.
  • Over 5 years, Accumulated Depreciation & Amortization stood at $3.2 million in 2021, then skyrocketed by 279.71% to $12.2 million in 2022, then dropped by 1.24% to $12.1 million in 2023, then increased by 1.89% to $12.3 million in 2024, then soared by 284.24% to $47.3 million in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $47.3 million, $46.7 million, and $44.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.